echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Clinical transition smooth patients benefit most obviously - the collection of crown vein stent "landing" the first week of observation

    Clinical transition smooth patients benefit most obviously - the collection of crown vein stent "landing" the first week of observation

    • Last Update: 2021-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    At 0:19 on January 1st, the patient successfully implanted 590 yuan of crown stent at the First People's Hospital in Zhangzhou City, Hunan Province; As of the 7th, the crown bracket, which fell within 1,000 yuan, has landed in 18 provinces and cities, including Beijing, Tianjin, Hunan, Shanxi and Xinjiang (including the Corps).
    reporter learned that, although the price of stents dropped significantly, but many medical institutions carried out by the persethopal coronary artery intervention surgery (PCI) volume did not show a significant increase, clinicians generally feedback product transition is stable, the most obvious benefits to patients.
    the patient feel when they use a cheap stent? Don't you rest assured? The 63-year-old, who is from Beihu District of Zhangzhou City, was rushed to the First People's Hospital "Chest Pain Center" of Zhangzhou City on December 31, 2020 due to sudden chest pain, and was admitted to the catheter room at 23:55 for a coronary anthosis examination, which was diagnosed as a severe stenosis of the left frontal branch of the coronary artery and required surgery as soon as possible.
    prepared, on January 1, 2021, at 00:19, wang Zhonghua, director of cardiovascular medicine at the hospital, performed coronary stent intervention therapy on him.
    its placement of the coronary repamycin wash-free drilling-based alloy support system for the Shanghai minimally invasive medical device company production, after the national collection, the price from 7200 yuan to 590 yuan.
    successfully completed, Mr. Li also became the first patient to feel the benefits of the national health care reform in the New Year.
    New Year's Day alone, the First People's Hospital of Zhangzhou City implemented a "100-yuan grade" low-cost coronary stent intervention treatment for 8 patients.
    , I had two stents implanted in Changsha because of a heart attack.
    also put two brackets this time, saving more than $13,000 in this alone.
    ," Mr. Li told reporters.
    in accordance with the collection rules, the first batch of national centralized belt procurement selected 10 crown brackets landed on January 1.
    the average price of this batch of selected brackets fell from about 13,000 yuan to about 700 yuan, of which the highest price was 798 yuan, the lowest price was 469 yuan.
    reporters from the State Health Security Administration learned that as of January 7, the collection bracket has landed in Beijing, Hunan, Shanxi and other 18 provinces and cities, the rest of the provinces will also land in January.
    the first batch of 18 provinces and municipalities to land in the local inventory of products reached an average of 33% of the agreed procurement, to meet the first month of medical institutions to meet the demand.
    For patients most concerned about the quality of stents, the national organization of high-value medical supplies joint procurement office director, Tianjin Municipal Medical Security Bureau Deputy Director Zhang Tiejun said that this collection has long been targeted "four" safeguards, "the stability of the quality of the collection bracket can be guaranteed."
    The first security is its "third type of medical equipment", any adjustment to raw materials, production processes, should be reported to the State Drug Administration for approval, and strict inspection; Guarantee is the competent departments to act quickly, has been deployed from the production, sales, use and other key supervision of the whole process, the fourth guarantee is the newly established pharmaceutical prices and investment procurement credit evaluation system, product quality and enterprise credit evaluation linked, so the collection bracket quality has a long-term, stable regulatory closed loop, patients can rest assured that use.
    see the effect of collection, clinicians "relieved" crown stent cheap, will not focus on releasing the need for surgery? The answer is in the long and short term.
    " use has not changed much these days, including the patient ratio, the number of operations are similar.
    " Shanxi Cardiovascular Hospital Department of Cardiovascular Medicine 15 District Director Wei Shoudong said, there are indeed some patients would have had surgery years ago, wait until January 1 to do the situation, but this situation must first meet the surgical safety signs, clinicians will do a good job with patients to communicate and explain that the operation will never be delayed.
    as a leading cardiovascular specialist hospital in China and the world for heart intervention and open chest surgery, the hospital is one of the "windows" to observe the clinical use of coronary stents.
    " winning 10 products, our hospital has 7 kinds, basically our hospital is usually in use, domestic and imported, bracket model is not everyone worried about the product after the time.
    , vice president of the hospital, said that in general, the collection of stents are clinical use of more mature products, basically to meet clinical needs.
    " at present, the product switch is relatively smooth, patients are satisfied, we are relieved.
    " she said, as the full application of collection stents has just begun after New Year's Day, and more feedback from clinicians is needed.
    the release effect of low-cost stents on surgical demand, Yang Weixian believes that in the long run it will not necessarily blow out.
    because of the low proportion of the overall use of coronary stents in China, in addition to price issues, including remote areas do not have surgery time conditions, inadequate primary medical technology and so on.
    two things the deans were most worried about after they landed? "As a consumer, we are actually most concerned about whether the winning product can meet our clinical needs, is not our usual use, feel good quality, use better some brackets.
    " Yang Weixian said the collection "basically met our expectations."
    it is understood that the collection bracket landing in the hospital, is not the price tag changed so simple, but to go through the return of the original price of products, buy new price products and other procedures.
    This means that on January 1st zero-point price switch, product stocking, collection stents for patients are new products, hospitals have to pay a lot of manpower and material resources to ensure that patients do not feel any change, or suffer any loss.
    obviously, there will be a part of the selected products are unfamiliar with or not used hospitals, short-term conversion pressure is very high. More than
    deans told reporters that after the collection bracket landed, their two biggest concerns are whether the patient's needs can be met, the second thing is whether the collection of follow-up policy support can keep up.
    the core of the belt procurement is to really "take the volume", otherwise the reform will not be sustainable.
    "quantity" of this collection bracket, covering more than 70% of the intended use of medical institutions around the country, almost 1.07 million.
    you make sure you have enough "quantity" and use it on the cutting edge? Yang Weixian said that the hospital will take a more accurate evaluation method, such as every one or two weeks to organize clinicians and supplies management personnel to communicate with each other, to grasp which some use more, which use very little, in order to ensure that patients meet the clinical needs of the premise, as scheduled to complete the collection of stent tasks.
    at present, the conventional stent implant surgery includes three medical services charges, the national average fee is: crown shadow 2240 yuan, balloon expansion 2600 yuan, put the stent 3680 yuan, a total of about 8500 yuan.
    this does not include the cost of various inspections.
    , in terms of the cost of coronary stent implant surgery, it basically reflects the labor value of medical personnel.
    of course, there are some areas of low fees, will choose a reasonable increase.
    such as Beijing coronary stent implant surgery three medical services the total original price is 5650 yuan, from January 1 this year to 6670 yuan.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.